Orphan designation: serabelisib Treatment of PIK3CA related overgrowth spectrum, 20/05/2026 Positive
EMA/PE/0000235869
EMA/PE/0000239491
EMA/PE/0000222352
EMA/PE/0000240548
Download website data in JSON data format
Human medicines European public assessment report (EPAR): Fluenz, influenza vaccine (live attenuated, nasal), Date of authorisation: 03/06/2024, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 6, Status: Authorised
List of medicines currently in PRIME scheme